Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

Gilead Sciences

Hematology

Hematology Video Recap—February 9, 2026

Hematology biweekly video highlighting regulatory actions across cancer and…

Onco_background

Oncology Today—November 10, 2025

This week’s Oncology update spotlights key developments, regulatory milestones,…

Public_Health

Public Health Weekly News - September 26th 2025

Public Health Update: Huntington’s Gene Therapy, Low-Cost HIV PrEP, New…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Hematology Today—February 16, 2026
Oncology Video Recap—February 16, 2026
Oncology Today—February 16, 2026
Lucid Diligence Brief: Genhouse Bio and Gilead in GH31 synthetic-lethal oncology $1.5B deal
Lucid Diligence Brief: Disc Medicine bitopertin FDA CRL

Tags

AHA 2025 AI for Science AI in Aesthetics Amycretin AtriCure Biorep Technologies Bispecific antibody therapy blood biomarkers BMJ cancer CB1 pathway Clinical Decision-Making Dayra Therapeutics Debio 4126 EADV 2025 Elismetrep Elranatamab ENHANZE EpiEndo Pharmaceuticals FDA oncology approvals Fenfluramine G6PD deficiency Heartnote heart valve treatment hematology Hematology strategy Ischemic heart disease Lilly ExploR&D mitapivat mRNA therapeutics muscarinic Nipah virus infection non viral vectors Obesity strategy pediatric urology peptibody mRNA therapy pharma Psychiatric disorders Recessive dystrophic epidermolysis bullosa Rybrevant FASPRO Samsung Bioepis Sema4 T-cell engagers Thermo Fisher TNFα

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Hematology Today—February 16, 2026
Oncology Video Recap—February 16, 2026
Oncology Today—February 16, 2026
Lucid Diligence Brief: Genhouse Bio and Gilead in GH31 synthetic-lethal oncology $1.5B deal
Lucid Diligence Brief: Disc Medicine bitopertin FDA CRL

TAGS

AHA 2025 AI for Science AI in Aesthetics Amycretin AtriCure Biorep Technologies Bispecific antibody therapy blood biomarkers BMJ cancer CB1 pathway Clinical Decision-Making Dayra Therapeutics Debio 4126 EADV 2025 Elismetrep Elranatamab ENHANZE EpiEndo Pharmaceuticals FDA oncology approvals Fenfluramine G6PD deficiency Heartnote heart valve treatment hematology Hematology strategy Ischemic heart disease Lilly ExploR&D mitapivat mRNA therapeutics muscarinic Nipah virus infection non viral vectors Obesity strategy pediatric urology peptibody mRNA therapy pharma Psychiatric disorders Recessive dystrophic epidermolysis bullosa Rybrevant FASPRO Samsung Bioepis Sema4 T-cell engagers Thermo Fisher TNFα

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy